Katharina Hauck is a Professor in Health Economics and Deputy Director of the Abdul Latif Jameel Institute for Disease and Emergency Analytics (Jameel Institute), School of Public Health, Imperial College London. She is specialized in the economics of infectious diseases and the economic evaluation of complex public health interventions. Her research comprises of the core health economics fields of cost-effectiveness analysis, universal health coverage and priority setting. Katharina's broader research interests include the micro- and macro-economic impacts of endemic infectious disease and epidemics, the economics of malaria elimination, health system strengthening, and the role of individual behavior in infectious disease transmission.
Katharina holds a PhD in Economics from the University of York (2005). Her previous appointments were at the Business School of Imperial College London (2010-2015), the Department of Econometrics and Business Statistics, Monash University (Australia, 2005-2010), the Centre for Health Economics, University of York (UK, 1999-2005), and the World Health Organization in Geneva (Switzerland, 1998-1999).
Katharina leads several collaborative studies in low-and middle-income countries, including the economic evaluation of HPTN071/PopART, a landmark study on the impact of a combination prevention package on population-level HIV incidence in Zambia and South Africa, and STARmeds, a study on falsified and substandard medicines in Indonesia. She is co-convener of the economic analysis for the Infected Blood Inquiry in the United Kingdom. Katharina is also a member of several senior expert advisory groups, and an associate editor for the journal 'Health Economics'. She was previously co-chair for Economics of The Global Fund's Modelling Secretariat for the investment case of the 6th replenishment, and a Postdoctoral Fellow of the Australian Research Council.
et al., 2021, Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial, The Lancet Global Health, Vol:9, ISSN:2214-109X, Pages:e668-e680
et al., 2021, The J-IDEA pandemic planner: a framework for implementing hospital provision interventions during the COVID-19 pandemic, Medical Care, Vol:59, ISSN:0025-7079, Pages:371-378
et al., 2021, Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States, Proceedings of the National Academy of Sciences of the United States of America, Vol:118, ISSN:0027-8424
et al., 2020, Adapting hospital capacity to meet changing demands during the COVID-19 pandemic, BMC Medicine, Vol:18, ISSN:1741-7015, Pages:1-12
Hauck K, Miraldo M, Singh S, 2020, Integrating motherhood and employment: a 22-year analysis investigatingimpacts of US workplace breastfeeding policy, Social Science and Medicine – Population Health, Vol:11, ISSN:2352-8273
Miraldo M, Lau K, Hauck K, 2019, Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England, Health Economics, Vol:28, ISSN:1057-9230, Pages:175-188
Hauck KD, 2018, The economics of infectious diseases, Oxford Research Encyclopedia of Economics and Finance, Editor(s): Jones, Oxford University Press
et al., 2022, Report 51: Valuing lives, education and the economy in an epidemic: Societal benefit of SARS-CoV-2 booster vaccinations in Indonesia
et al., 2020, Report 40: Optimal scheduling rules for elective care to minimize years of life lost during the SARS-CoV-2 pandemic: an application to England
et al., 2020, DAEDALUS: An economic-epidemiological model to optimize economic activity while containing the SARS-CoV-2 pandemic
et al., 2020, Report 35: How can we keep schools and universities open? Differentiating closures by economic sector to optimize social and economic activity while containing SARS-CoV-2 transmission
et al., 2020, Report 27 Adapting hospital capacity to meet changing demands during the COVID-19 pandemic